News|Articles|December 8, 2023
NeurologyLive® Friday 5 — December 8, 2023
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 8, 2023.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Embracing New Approaches to Seizure Control Beyond Surgery: Gregory Krauss, MD
The professor of neurology at Johns Hopkins University School of Medicine discussed the traditional view of epilepsy treatment and how the paradigm has shifted to provide new treatments to achieve seizure freedom for drug-resistant patients. [WATCH TIME: 5 minutes]
2: How Surgical Interventions Improve Survival Rate in Pediatric Epilepsy: Sandi K. Lam, MD, MBA
The division chief of pediatric neurosurgery at Ann & Robert H. Lurie Children's Hospital of Chicago talked about findings from a recently published study on long-term survival of pediatric patients with drug-resistant epilepsy which was presented at AES 2023. [WATCH TIME: 6 minutes]
3: NeuroVoices: Cathleen Lutz, MD, on the Potential of Stathmin-2 as an ALS-Specific Biomarker
In this edition of NeuroVoices, the vice president of the Rare Disease Translational Center at the Jackson Laboratory provided context on a recently published study suggesting restoration of stathmin-2 as a therapeutic approach for ALS.
4: BTKi Treatment: Clinical Measures
In this Peer Exchange episode of the "Novel Mechanisms of Action in Multiple Sclerosis: Focus on BTK Inhibitors" video series, experts provide insights about what clinical measures they look for when treating patients with BTKis for multiple sclerosis.
5: Overview of Huntington’s Disease (HD)
In this NeurologyLive Insights episode of the "An Expert Approach to Navigating the Complexities of Huntington’s Disease," video series, Daniel Claassen, MD, MS, provides an overview of the pathophysiology and genetic background of Huntington’s disease (HD), a neurodegenerative disorder.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
NeurologyLive® Friday 5 — September 12, 2025
3
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
4
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
5